These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11251582)

  • 1. Severe recalcitrant pyoderma gangrenosum responding to a combination of mycophenolate mofetil with cyclosporin and complicated by a mononeuritis.
    Gilmour E; Stewart DG
    Br J Dermatol; 2001 Feb; 144(2):397-400. PubMed ID: 11251582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycophenolate mofetil and cyclosporin treatment for recalcitrant pyoderma gangrenosum.
    Hohenleutner U; Mohr VD; Michel S; Landthaler M
    Lancet; 1997 Dec; 350(9093):1748. PubMed ID: 9413469
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapy-resistant pyoderma gangrenosum--treatment with mycophenolate mofetil and cyclosporine A].
    Michel S; Hohenleutner U; Mohr V; Landthaler M
    Hautarzt; 1999 Jun; 50(6):428-31. PubMed ID: 10427512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of recalcitrant ulcers in pyoderma gangrenosum with mycophenolate mofetil and autologous keratinocyte transplantation on a hyaluronic acid matrix.
    Wollina U; Karamfilov T
    J Eur Acad Dermatol Venereol; 2000 May; 14(3):187-90. PubMed ID: 11032062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycophenolate mofetil as therapy for pyoderma gangrenosum.
    Eaton PA; Callen JP
    Arch Dermatol; 2009 Jul; 145(7):781-5. PubMed ID: 19620559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycophenolate mofetil in pyoderma gangrenosum.
    Lee MR; Cooper AJ
    J Dermatolog Treat; 2004 Sep; 15(5):303-7. PubMed ID: 15370398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effectiveness of mycophenolate mofetil in refractory pyoderma gangrenosum.
    Nousari HC; Lynch W; Anhalt GJ; Petri M
    Arch Dermatol; 1998 Dec; 134(12):1509-11. PubMed ID: 9875186
    [No Abstract]   [Full Text] [Related]  

  • 8. Pyoderma gangrenosum associated with Wegener's granulomatosis: partial response to mycophenolate mofetil.
    Le Hello C; Bonte I; Mora JJ; Verneuil L; Noël LH; Guillevin L
    Rheumatology (Oxford); 2002 Feb; 41(2):236-7. PubMed ID: 11886982
    [No Abstract]   [Full Text] [Related]  

  • 9. Mycophenolate mofetil is an effective treatment for peristomal pyoderma gangrenosum.
    Daniels NH; Callen JP
    Arch Dermatol; 2004 Dec; 140(12):1427-9. PubMed ID: 15611417
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of pyoderma gangrenosum with mycophenolate mofetil as a steroid-sparing agent.
    Li J; Kelly R
    J Am Acad Dermatol; 2013 Oct; 69(4):565-9. PubMed ID: 23850090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyoderma gangrenosum complicating ulcerative colitis: Successful treatment with methylprednisolone pulse therapy and cyclosporine.
    Futami H; Kodaira M; Furuta T; Hanai H; Kaneko E
    J Gastroenterol; 1998 Jun; 33(3):408-11. PubMed ID: 9658322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycophenolate mofetil as adjunctive therapy to corticosteroids for the treatment of pyoderma gangrenosum: a case series and literature review.
    Hrin ML; Bashyam AM; Huang WW; Feldman SR
    Int J Dermatol; 2021 Dec; 60(12):e486-e492. PubMed ID: 33739458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycophenolate mofetil and skin diseases.
    Hartmann M; Enk A
    Lupus; 2005; 14 Suppl 1():s58-63. PubMed ID: 15803935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recalcitrant oral pyoderma gangrenosum in a child responsive to cyclosporine.
    Park HJ; Han BG; Kim YC; Cinn YW
    J Dermatol; 2003 Aug; 30(8):612-6. PubMed ID: 12928531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The simultaneous treatment of inflammatory bowel diseases and associated pyoderma gangrenosum with oral cyclosporin A.
    Capella GL; Frigerio E; Fracchiolla C; Altomare G
    Scand J Gastroenterol; 1999 Feb; 34(2):220-1. PubMed ID: 10192206
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclosporine, azathioprine and local therapy for pyoderma gangrenosum.
    Duffill MB
    Australas J Dermatol; 1994; 35(1):15-8. PubMed ID: 7998894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyoderma gangrenosum associated with Takayasu's arteritis responding to cyclosporin.
    Fearfield LA; Ross JR; Farrell AM; Costello C; Bunker CB; Staughton RC
    Br J Dermatol; 1999 Aug; 141(2):339-43. PubMed ID: 10468813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Letter: Treatment-resistant pyoderma gangrenosum.
    Kosari P; Feldman SR
    Dermatol Online J; 2012 Apr; 18(4):8. PubMed ID: 22559023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimodal therapy of idiopathic pyoderma gangrenosum.
    Sharon V; Burrall B; Patel F; He Y; Konia T; Villalobos IB; Maverakis E
    Dermatol Online J; 2014 Jun; 20(6):. PubMed ID: 24945643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sarcoidosis and pyoderma gangrenosum: an exceptional association. The role of trauma and immunosuppressive agents.
    Herrero JE; Mascaró JM; Llambrich A; Herrero C
    J Eur Acad Dermatol Venereol; 2005 Jan; 19(1):97-9. PubMed ID: 15649201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.